The findings indicated that the expression of ACTA2 [33,34] and MYH11 in tumor samples of both datasets was significantly lower than that in normal samples, and the low expression of MYH11 in tumor samples was more significant (Fig. 2D,E). The gene discussed is ACTA2; the disease is neoplasm.